These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The prognostic significance of the BRAF V600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry. McKelvie PA; Chan F; Yu Y; Waring P; Gresshoff I; Farrell S; Williams RA Pathology; 2013 Dec; 45(7):637-44. PubMed ID: 24247620 [TBL] [Abstract][Full Text] [Related]
43. Usefulness of S100A9 for diagnosis of intrathyroid epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE). Ito Y; Miyauchi A; Arai K; Nozawa R; Miya A; Kobayashi K; Nakamura Y; Kakudo K Pathology; 2006 Dec; 38(6):541-4. PubMed ID: 17393982 [TBL] [Abstract][Full Text] [Related]
44. [Salivary carcinoma showing thymus-like differentiation: clinicopathological analysis of 7 cases]. Zhang CY; Gu T; Xia S; Wang Y; Li J Zhonghua Kou Qiang Yi Xue Za Zhi; 2024 May; 59(5):479-485. PubMed ID: 38637002 [No Abstract] [Full Text] [Related]
45. Carcinoma showing thymus-like differentiation (CASTLE): a case report. Geraci G; Lo Nigro C; Sciuto A; Modica R; Francesco C; Sciumè C; Attard A; Modica G Ann Ital Chir; 2013; 84(1):77-80. PubMed ID: 23445782 [TBL] [Abstract][Full Text] [Related]
46. CASTLE tumor of the parotid: First documented case, literature review, and genetic analysis of the cancer. Wong EHC; Tetter N; Tzankov A; Muller L Head Neck; 2018 Jan; 40(1):E1-E4. PubMed ID: 29120527 [TBL] [Abstract][Full Text] [Related]
47. Thyroid carcinoma showing thymus-like differentiation (CASTLE): case report with cytomorphology and review of the literature. Youens KE; Bean SM; Dodd LG; Jones CK Diagn Cytopathol; 2011 Mar; 39(3):204-9. PubMed ID: 20607745 [TBL] [Abstract][Full Text] [Related]
48. CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffin-embedded tissue. Berezowski K; Grimes MM; Gal A; Kornstein MJ Am J Clin Pathol; 1996 Oct; 106(4):483-6. PubMed ID: 8853036 [TBL] [Abstract][Full Text] [Related]
49. Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation. Kalhor N; Moran CA Hum Pathol; 2018 Apr; 74():73-82. PubMed ID: 29339175 [TBL] [Abstract][Full Text] [Related]
50. Carcinoma showing thymus-like differentiation of the parotid gland: The brief report of cytomorphology and review of the literature. Uchiyama T; Terada C; Tachibana Y; Nishiura H; Takeda M; Fujii T; Kimura T; Tsutsumi M; Ohbayashi C Diagn Cytopathol; 2023 Mar; 51(3):E98-E104. PubMed ID: 36484759 [TBL] [Abstract][Full Text] [Related]
51. Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas. Nakayama H; Yoshida A; Nakamura Y; Hayashi H; Miyagi Y; Wada N; Rino Y; Masuda M; Imada T Anticancer Res; 2007; 27(5B):3645-9. PubMed ID: 17972530 [TBL] [Abstract][Full Text] [Related]
52. Absence of gene mutations in KIT-positive carcinoma showing thymus-like elements of the thyroid. Pan Y; Zhao X; Yang J; Deng J; Zhan Z; Luo Y; Li Q; Guo Y; Zhai Q; Sun B Hum Pathol; 2012 Mar; 43(3):350-5. PubMed ID: 21835435 [TBL] [Abstract][Full Text] [Related]
53. [Thyroid squamous-cell carcinoma showing thymus-like element (CASTLE): a report of eight cases]. Da J; Shi H; Lu J Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):303-4. PubMed ID: 11776823 [TBL] [Abstract][Full Text] [Related]
54. Cytologic Diagnosis of "CASTLE" of thyroid gland: report of a case with histologic correlation. Ng WK; Collins RJ; Shek WH; Ng IO Diagn Cytopathol; 1996 Sep; 15(3):224-7. PubMed ID: 8955605 [TBL] [Abstract][Full Text] [Related]
55. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights. Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187 [TBL] [Abstract][Full Text] [Related]
56. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas. Routhier CA; Mochel MC; Lynch K; Dias-Santagata D; Louis DN; Hoang MP Hum Pathol; 2013 Nov; 44(11):2563-70. PubMed ID: 24071017 [TBL] [Abstract][Full Text] [Related]
57. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors. Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049 [TBL] [Abstract][Full Text] [Related]
58. Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis. Li J; Xiang R; Li Y; Liao Q; Liu Y Virchows Arch; 2023 May; 482(5):813-822. PubMed ID: 37016248 [TBL] [Abstract][Full Text] [Related]
59. [The clinical analysis of thyriod carcinoma showing thymus-like differentiation]. Liang J; Huang H; Li L; Luo H; Huang M; Zhang X; Gao S; Mao W Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Oct; 29(19):1736-8. PubMed ID: 26999850 [TBL] [Abstract][Full Text] [Related]
60. Spindle epithelial tumor with thymus-like differentiation (SETTLE) of the thyroid with neck lymph node metastasis: a case report. Abrosimov AY; LiVolsi VA Endocr Pathol; 2005; 16(2):139-43. PubMed ID: 16199899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]